Cookson Peirce & Co. Inc. Acquires 2,326 Shares of Integer Holdings Co. (NYSE:ITGR)

Cookson Peirce & Co. Inc. grew its position in shares of Integer Holdings Co. (NYSE:ITGR) by 56.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,432 shares of the medical equipment provider’s stock after purchasing an additional 2,326 shares during the quarter. Cookson Peirce & Co. Inc.’s holdings in Integer were worth $852,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of Integer by 4.4% during the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock valued at $220,000 after purchasing an additional 71 shares in the last quarter. HighTower Advisors LLC lifted its stake in shares of Integer by 0.8% in the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock worth $1,579,000 after acquiring an additional 90 shares during the period. Norden Group LLC lifted its stake in shares of Integer by 7.0% in the fourth quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider’s stock worth $221,000 after acquiring an additional 109 shares during the period. State of New Jersey Common Pension Fund D lifted its stake in shares of Integer by 0.9% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 15,722 shares of the medical equipment provider’s stock worth $2,083,000 after acquiring an additional 140 shares during the period. Finally, Mather Group LLC. lifted its stake in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 143 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ITGR has been the topic of a number of recent analyst reports. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. KeyCorp boosted their price target on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Truist Financial boosted their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, Citigroup boosted their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Integer presently has an average rating of “Moderate Buy” and a consensus price target of $147.67.

Integer Trading Up 3.9 %

NYSE ITGR opened at $122.87 on Thursday. The business has a 50 day moving average price of $136.01 and a 200-day moving average price of $132.95. Integer Holdings Co. has a 52 week low of $107.11 and a 52 week high of $146.36. The company has a market cap of $4.13 billion, a price-to-earnings ratio of 36.57, a P/E/G ratio of 1.72 and a beta of 1.13. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. As a group, equities analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.